The Wnt signaling pathway regulates Nalm-16 b-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance

Biomedicine and Pharmacotherapy

Volumn 64, Issue 1, 2010, Pages 63-72

  Thiago, L S ^a   Costa, E S ^a   Lopes, D V ^a   Otazu, I B ^a,b   Nowill, A E ^c   Mendes, F A ^a   Portilho, D M ^a   Abreu, J G ^a   Mermelstein, C S ^a   Orfao, A ^d   Rossi, M I D ^a   Borojevic, R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d CSIC   (Spain)

Author keywords

B Cell precursor acute lymphoblastic leukemia; Drug resistance; Wnt signaling pathway

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; ETOPOSIDE; LITHIUM CHLORIDE; ONCOSIDEO; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; DRUG SENSITIVITY; EMBRYO; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; LEUKEMIA CELL LINE; MOUSE; NALM 16 CELL LINE; NALM 6 CELL LINE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA CATENIN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 73149114384     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.09.005     Document Type: Article

References (31)

1. Pui C.-H., Relling M.V., Campana D., and Evans W.E. Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol 62 (2002) 161-179
2. Manabe A., Murti K.G., Coustan-Smith E., Kumagai M., Behm F.G., Raimondi S.C., et al. Adhesion dependent survival of normal and leukemic human B lymphoblasts. Blood 83 (1994) 758-766
3. Kumagai M., Manabe A., Pui C.H., Behm F.G., Raimondi S.C., Hancock M.L., et al. Stroma-supported culture of childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 97 (1996) 755-760
4. Kléber M., and Sommer L. Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 16 (2004) 681-687
5. Staal F.J.T., and Clevers H.C. Wnt signalling and haematopoiesis: a Wnt-Wnt situation. Nat Rev Immuno l5 (2005) 21-30
6. Dann C.E., Hsieh J.C., Rattner A., Sharma D., Nathans J., and Leahy D.J. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412 (2001) 86-90
7. Willert K., and Jones K.A. Wnt signaling: is the party in the nucleus?. Genes Dev 20 (2006) 1394-1404
8. Gordon M.D., and Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281 (2006) 22429-22433
9. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., and Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162 (2003) 899-908
10. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98 (2001) 10356-10361
11. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., et al. Epigenetic inactivation of SFRP genes allows constitutive Wnt signaling in colorectal cancer. Nat Genet 36 (2004) 417-422
12. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 17 (2007) 45-51
13. Chung E.J., Hwang S.G., Nguyen P., Lee S., Kim J.S., Kim J.W., et al. Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin. Blood 100 (2002) 982-990
14. Lu D., Zhao Y., Tawatao R., Cottam H.B., Sen M., Leoni L.M., et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 101 (2004) 3118-3123
15. Derksen P.W., Tjin E., Meijer H.P., Klok M.D., MacGillavry H.D., van Oers M.H., et al. Illegitimate Wnt signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci U S A 101 (2004) 6122-6127
16. Yaccoby S., Ling W., Zhan F., Walker R., Barlogie B., and Shaughnessy Jr. J.D. Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood 109 (2007) 2106-2111
17. Roth W., Wild-Bode C., Platten M., Grimmel C., Melkonyan H.S., Dichgans J., et al. Secreted-frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19 (2000) 4210-4220
18. Shou J., Ali-Osman F., Multani A.S., Pathak S., Fedi P., and Srivenugopal K.S. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 21 (2002) 878-889
19. De Toni F., Racaud-Sultan C., Chicanne G., Mas V.M., Cariven C., Mesange F., et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 25 (2006) 3113-3122
20. Nygren M.K., Døsen G., Hystad M.E., Stubberud H., Funderud S., and Rian E. Wnt3a activates canonical Wnt signalling in acute lymphoblastic leukemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 136 (2007) 400-413
21. Khan N.I., Bradstock K.F., and Bendall L.J. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukemia. Br J Haematol 138 (2007) 338-348
22. Serinsöz E., Neusch M., Büsche G., Wasielewski R., Kreipe H., and Bock O. Aberrant expression of beta-catenin discriminates acute myeloid leukemia from acute lymphoblastic leukemia. Br J Haematol 126 (2004) 313-319
23. Matsuo Y., and Drexler H.G. Establishment and characterization of human B cell precursor-leukemia cell lines. Leuk Res 22 (1994) 567-579
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem 193 (1951) 265-275
25. Vindelov L.L., Christensen I., and Nissen N.A. Detergent-trypsin method for the preparation of nuclei for flow cytometry. Cytometry 3 (1983) 323-327
26. Behrens J., von Kries J.P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642
27. Zhao C., Blum J., Chen A., Kwon H.Y., Jung S.H., Cook J.M., et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12 (2007) 528-541
28. Van Gijn M.E., Snel F., Cleutjens J.P.M., Smits J.F.M., and Blankesteijn W.N. Overexpression of components of the frizzled-disheveled cascade results in apoptotic cell death, mediated by β-Catenin. Exp Cell Res 265 (2001) 46-53
29. Kim K., Pang K.M., Evans M., and Hay E.D. Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol Biol Cell 11 (2000) 3509-3523
30. Etheridge S.L., Spencer G.J., Heath D.J., and Genever P.G. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22 (2004) 849-860
31. Jianming Y., Hongyu L., Yun-Wen C., Gopesh S., Zifen G., and Qian T. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 110 (2004) 4130-4131